Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Potential drug targets for multiple sclerosis identified through Mendelian randomization analysis.

Brain : a journal of neurology - 1 Aug 2023

Lin Jianfeng, Zhou Jiawei, Xu Yan

Abstract excerpt

Multiple sclerosis is a complex autoimmune disease, and several therapies for multiple sclerosis have been developed and widely used. However, existing medications for multiple sclerosis were far from satisfactory due to their failure to suppress relapses and alleviate disease progression. Novel drug targets for multiple sclerosis prevention are still needed. We performed Mendelian randomization to explore...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Bayes Theorem
Share to Genome-Wide Association Study
Share to Mendelian Randomization Analysis

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Multiple Sclerosis

Share to Multiple Sclerosis Research Studies

Share to Phenotype

Share to Polymorphism, Single Nucleotide

Share to Rheumatoid Arthritis Research and Therapies

Source

Open in PubMed Open full text

Identifiers

PMID: 36864689
DOI: 10.1093/brain/awad070
PMCID: PMC10393411

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 2 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Potential drug targets for multiple sclerosis identified through Mendelian randomization analysis.PMID 36864689Read ↗

Summary-data-based Mendelian randomization prioritizes potential druggable targets for multiple sclerosisSemantic proximity Read ↗

Integrating Genomic, eQTL, and Mendelian Randomization Analyses to Identify Microglial Drug Targets in Multiple Sclerosis.Semantic proximity Read ↗

Integrated analyses of single-cell transcriptome and Mendelian randomization reveal the protective role of FCRL3 in multiple sclerosis.Semantic proximity Read ↗

Multiple sclerosis as a genetic risk factor for Alzheimer's disease: Insights from Mendelian randomisation.Semantic proximity Read ↗

Multiple sclerosis: genetics, biomarkers, treatments.Semantic proximity Read ↗

Uncovering Potential Genetic Targets in the Mediating Role of Demyelinating Disease for Multiple Sclerosis-Induced Neuropathic Bladder: A Mendelian Randomization AnalysisSemantic proximity Read ↗

Mendelian randomization for autoimmune diseases: exploring causal links and drug targets in plasma proteomeSemantic proximity Read ↗

Identification of potential drug targets for amyotrophic lateral sclerosis by Mendelian randomization analysis based on brain and plasma proteomics.Semantic proximity Read ↗

An atlas on risk factors for multiple sclerosis: a Mendelian randomization studySemantic proximity Read ↗

Prioritization of therapeutic targets for amyotrophic lateral sclerosis using protein-wide Mendelian randomization analysisSemantic proximity Read ↗

Identification of lipid-modifying drug targets for autoimmune diseases: insights from drug target mendelian randomization.Semantic proximity Read ↗

Disentangling multiple sclerosis phenotypes through Mendelian disorders: A network approach.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.